Prices, supply limits, and prescription rules can change fast, which makes clear guidance important before making any decision
Key Industry Developments: In October 2025 , Eli Lilly and Company achieved its fourth Phase III success with its oral GLP-1 receptor agonist, orforglipron, in type 2 diabetes trials
It is not just about willpower
Watch For Thirst Red Flags: How To Spot Dehydration Early Headache Fatigue Lightheadedness Dry mouth Low urine output Urine that is dark yellow or amber If you have vomiting or diarrhea while on a weight loss drug, you face a higher risk of dehydration and should boost fluids and electrolytes
In Mandeville, Louisiana, patients have access to the latest FDA-approved oral option, the Wegovy pill, favoring those who opt not to use injections